Eckert & Ziegler SE (XTER:EUZ) EPS (Basic): €0.80 (TTM As of Mar. 2026)


XTER:EUZ Eckert & Ziegler SE XTER:EUZ
98 GF Score
Price €15.41
GF Value €16.25
Valuation Fairly Valued
View Full Analysis

What is Eckert & Ziegler SE EPS (Basic)?

Eckert & Ziegler SE XTER:EUZ -1.03% 98 EPS (Basic) is €0.80 as of Mar. 2026. GuruFocus rates XTER:EUZ with a GF Score™ of 98/100 and a GF Value™ of €16.25 (Fairly Valued).

Eckert & Ziegler SE's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €0.17. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.80.

Eckert & Ziegler SE's EPS (Diluted) for the three months ended in Mar. 2026 was €0.17. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €0.79.

Eckert & Ziegler SE's EPS without NRI for the three months ended in Mar. 2026 was €0.17. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.79.

During the past 12 months, Eckert & Ziegler SE's average EPS without NRIGrowth Rate was 5.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was 13.50% per year. During the past 5 years, the average EPS without NRI Growth Rate was 15.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 17.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Eckert & Ziegler SE's highest 3-Year average EPS without NRI Growth Rate was 70.60% per year. The lowest was -17.60% per year. And the median was 11.30% per year.

Eckert & Ziegler SE  (XTER:EUZ) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Eckert & Ziegler SE EPS (Basic) Related Terms

Eckert & Ziegler SE EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Eckert & Ziegler SE's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eckert & Ziegler SE EPS (Basic) Chart

Eckert & Ziegler SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.56 0.47 0.42 0.53 0.78

Eckert & Ziegler SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.19 0.14 0.30 0.17
XTER:EUZ
98GF Score
Eckert & Ziegler SE XTER:EUZ
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eckert & Ziegler SE EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Eckert & Ziegler SE's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(48.763-0)/62.563
=0.78

Eckert & Ziegler SE's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(10.372-0)/62.576
=0.17

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €0.80 mean?
Eckert & Ziegler SE (XTER:EUZ) has a EPS (Basic) of €0.80 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Eckert & Ziegler SE and its competitors.
Is Eckert & Ziegler SE's EPS (Basic) too high?
Eckert & Ziegler SE's current EPS (Basic) is €0.80. Overall, Eckert & Ziegler SE has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eckert & Ziegler SE's EPS (Basic) compare to ABT and SYK?
Eckert & Ziegler SE's EPS (Basic) of €0.80 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Eckert & Ziegler SE and its competitors. Eckert & Ziegler SE's current EPS (Basic) is €0.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eckert & Ziegler SE stock overvalued right now?
Based on GuruFocus' analysis, Eckert & Ziegler SE (XTER:EUZ) is currently considered Fairly Valued. The stock's GF Value™ is €16.25, compared to a current price of €15.41 — trading 5.2% below its estimated fair value. The current EPS (Basic) is €0.80. Eckert & Ziegler SE's overall GF Score™ is 98/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Eckert & Ziegler SE (XTER:EUZ), the current EPS (Basic) is €0.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eckert & Ziegler SE (XTER:EUZ) Overvalued in 2026?

Based on GuruFocus' analysis, Eckert & Ziegler SE stock appears to be undervalued. The current stock price of €15.41 is trading 5.2% below its estimated GF Value™ of €16.25. GuruFocus considers Eckert & Ziegler SE to be Fairly Valued.

Key valuation signals for XTER:EUZ:

  • EPS (Basic): €0.80
  • GF Value™: €16.25 vs. price of €15.41 (5.2% below fair value)
  • GF Score™: 98/100

No single metric tells the full story. See the XTER:EUZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eckert & Ziegler SE Business Description

Address Robert-Rossle-Street 10, Berlin, BB, DEU, 13125
Eckert & Ziegler SE is a holding company with specialised in the processing of radioisotopes and the development, production and sale of isotope technology components, radiopharmaceuticals and related products. It is an international manufacturer of isotope technology components for medical, scientific, and industrial applications. The group's products are mainly used in cancer therapy, nuclear imaging, and industrial metrology. The company's segments are Medical, Isotope Products, and Other. The majority of revenue comes from Medical segment which provides pharmaceutical-quality radioactive ingredients and markets products for the treatment and diagnosis of cancers. Geographically, the company generates a majority of its revenue from Europe and then North America, Asia/Pacific, and other.
98GF Score

Get the complete analysis for XTER:EUZ

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.41
Price
€16.25
GF Value